Japan: Acute Tubular Injury after Pfizer-BioNTech Injection

Were victims of the Poison Death Shots informed that their Kidneys might suffer Acute Injuries before they received an untested, unproven, and unsafe injection? No.

Feb 28, 2023

Did anyone who took the COVID-19 Gene Serum Injections know that Acute Kidney Injury was a possibility before they got injected?

No.

There was no informed consent as to the innumerable risks presented by an untested and unsafe medical treatment.

There will be more ‘conclusions’ like this in the months and years ahead.

Acute Tubular Injury — ATI

Acute Kidney Injury — AKI

Directly from the study which was accepted just a few days ago on February 17th:

To the best of our knowledge, this is the first reported case of pathologically proven ATI after a COVID-19 vaccine. Although mechanisms and cases need to be accumulated, physicians need to be aware that ATI might occur after COVID-19 vaccination.

Renal Biopsy Diagnosis of Acute Tubular Injury after Pfizer-BioNTech COVID-19 Vaccination: A Case Report

Pubmed via MDPI

However, acute kidney injury (AKI) after COVID-19 vaccination is a rare adverse reaction that has not been reported in previous trials [3,4,5]. Conversely, rare conditions requiring treatment with immunosuppressive agents, such as acute glomerulonephritis, have been reported as a cause of AKI after vaccination. COVID-19 vaccines reportedly result in adverse events in the form of renal diseases, such as minimal change disease [6], IgA nephropathy [7], vasculitis [8,9], acute tubulointerstitial nephritis [10], and thrombotic microangiopathy (TMA) [11]. Most cases require treatment with immunosuppressive drugs and often result in AKI. However, no case of AKI pathology with acute tubular injury (ATI) alone after receiving a COVID-19 vaccine has been reported to date. Herein, we present a case in which the AKI pathology was ATI only and demonstrate the importance of excluding patients with diseases that require treatment with immunosuppressive drugs, such as vasculitis and nephritis. Conservative treatment without immunosuppressive drugs can improve the patient’s condition when ATI is the sole cause of the AKI.

“Rare adverse reaction that has not been reported in previous trials.”

There are still new side effects being discovered every day.

Conclusion:

In conclusion, we reported a case in which a COVID-19 vaccine might have caused AKI with ATI as the sole pathology, which may not require immunosuppressive drugs. On the other hand, acute glomerulonephritis caused by a COVID-19 vaccine requires immunosuppressive drugs, without which the disease may have a severe course, including progression to ESKD. Therefore, in cases of AKI after COVID-19 vaccination with an unclear cause, such as sepsis, performing an aggressive renal biopsy should be considered for differential diagnosis. To the best of our knowledge, this is the first reported case of pathologically proven ATI after a COVID-19 vaccine. Although mechanisms and cases need to be accumulated, physicians need to be aware that ATI might occur after COVID-19 vaccination.

Ivermectin may be able to help: